Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion type Assertion NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_head.
- NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion description "[Mexiletine, a class IB Na+ channel blocker, dose-dependently (2-20 micromol/L) abbreviated the QT and APD more in the LQT3 model, but decreased TDR and suppressed TdP in the 3 models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_provenance.
- NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion evidence source_evidence_literature NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_provenance.
- NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion SIO_000772 10688323 NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_provenance.
- NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion wasDerivedFrom befree-20150227 NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_provenance.
- NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_assertion wasGeneratedBy ECO_0000203 NP683047.RAH3flJbz7d-07gMw469NyPaUqGcsSEkC5OOHOADcF684130_provenance.